Cited by 119Immune cells in cancerCancer, Stress, Anesthesia, and Immune ResponseImmune Response and Inflammation

Mechanisms linking pathogens-associated inflammation and cancer

Porta, Chiara, Riboldi, Elena, Sica, Antonio·2011·Cancer Letters

Abstract

It has been estimated that chronic infections with viruses, bacteria and parasites are the causative agents of 8-17% of global cancers burden. Carcinogenesis associated with infections is a complex process, often mediated by chronic inflammatory conditions and accumulating evidence indicate that a smouldering inflammation is a component of the tumor microenvironment and represents the 7th hallmark of cancer. Selected infectious agents promote a cascade of events culminating in chronic inflammatory responses, thus predisposing target tissues to increased cancer susceptibility. A causal link also exists between an inflammatory microenvironment, consisting of inflammatory cells and mediators, and tumor progression. Tumor-Associated Macrophages (TAM) represent the major inflammatory population present in tumors, orchestrating various aspects of cancer, including: diversion and skewing of adaptive responses; cell growth; angiogenesis; matrix deposition and remodelling; construction of a metastatic niche and actual metastasis; response to hormones and chemotherapeutic agents. Recent studies on human and murine tumors indicate that TAM show a remarkable degree of plasticity and functional heterogeneity, during tumour development. In established tumors, TAM acquire an M2 polarized phenotype are engaged in immunosuppression and the promotion of tumor angiogenesis and metastasis. Being a first line of the innate defence mechanisms, macrophages are also equipped with pathogen-recognitio…

Integrity signals

Registry

Crossref · 10.1016/j.canlet.2010.10.012

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The extrinsic pathway of tumorigenesis is initially characterized by a chronic pro-inflammatory environment from persistent microbial infection, autoimmune disease, or unknown etiology.

    “This “extrinsic pathway” is initially characterized by a chronic pro-inflammatory environment resulting from a persistent microbial infection, autoimmune disease, or other etiology of unknown origin [37,38].”
  • Chronic production of inflammatory mediators can lead to tumor cell proliferation/survival or genetic instability in normal cells, resulting in oncogene expression and immune suppressive cytokines.

    “The chronic production of large quantities of inflammatory mediators in these cases can lead, through a number of pathways, to tumor cell proliferation and survival or to the induction of genetic instabilities in normal cells, with resultant expression of oncogenes and production of immune suppressive cytokines [37,38].”
  • Early tumor development is often characterized by a polarized inflammatory M1-like environment.

    “Thus, early tumor development is, in many cases, characterized by a polarized inflammatory, M1-like, environment.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Porta, C., Riboldi, E., & Sica, A.
Affiliations
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
Corresponding author
Sica, Antonio
Venue
Cancer Letters
Publisher
Elsevier BV
Published
2011-06
Volume
305
Issue
2
Pages
250-262
ISSN
0304-3835 (ISSN-L)
OpenAlex
W2046502194
Cited by
119
References
11
Citations by year
2026: 5 · 2025: 4 · 2024: 5 · 2023: 9 · 2022: 5 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 3 · 2017: 11 · 2016: 5 · 2015: 10 · 2014: 15 · 2013: 7 · 2012: 15
FWCI
0.69
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Letters (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Associazione Italiana Ricerca sul Cancro (AIRC), Italy
  • Fondazione Cariplo, Italy
  • Ministero Università Ricerca (MUR), Italy
  • Ministero della Salute
  • Regione Piemonte
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Psychiatry and Mental health › Cancer, Stress, Anesthesia, and Immune Response
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
chronic inflammation, infection-associated cancer, tumor microenvironment, tumor-associated macrophages, M2 macrophage polarization, pathogen recognition receptors, tumor angiogenesis, metastasis, immunosuppression, cancer prevention, cancer therapy
MeSH terms
Animals, Humans, Inflammation, Macrophages, Mice, Transgenic, Neoplasms, Phenotype, Signal Transduction, Cytokines, NF-kappa B, Oxidative Stress, Mice, Cyclooxygenase 2, Hypoxia-Inducible Factor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review